相关实验视频

Updated: Jul 16, 2025

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

骨质疏松素变体与系统性红斑狼之间的关联:一个元分析

Young Ho Lee¹, Gwan Gyu Song¹

¹Department of Rheumatology, Korea University Medical Center, Korea University College of Medicine, Seoul, Korea.

Genetic testing and molecular biomarkers

|September 11, 2023

概括

骨质疏松素 (OPN) 基因变异与系统性红斑狼 (SLE) 易感性有关. 在OPN 707 T/C和1239 C/A变种中,在各种族群中显示出与SLE的显著关联.

科学领域:

免疫遗传学免疫遗传学
类风湿病学类风湿病学

背景情况:

骨质疏松素 (OPN) 在免疫系统调节中起着至关重要的作用,影响T细胞和B细胞的反应.
对OPN功能的调节失调与自身免疫性疾病有关.

研究的目的:

调查特定的骨质素 (OPN) 基因变异与对系统性红斑狼 (SLE) 的敏感性之间的关联.
分析OPN变异对不同族裔人口中SLE风险的影响.

主要方法:

使用来自Medline,Embase和KoreaMed数据库的数据进行了全面的元分析.
包括的研究分析了OPN变体:707 T/C (rs1126616),1083 G/A (rs112772),1239 C/A (rs9138) 和9250 T/C (rs11229919).这些研究包括在内.
统计分析涉及计算几率比率 (OR) 和95%置信区间 (CI) 以评估与SLE的关联.

主要成果:

在OPN 707 T等位基因与SLE易感性 (OR=1.522,p=0.044) 之间发现了显著的关联,特别是在欧洲和阿拉伯人群中.
在亚洲和阿拉伯人口中,OPN 9250 C等位基因与SLE有显著的关联.
OPN 1239 C/A 变种也显示出与 SLE 的显著关联 (OR=1.192,p=0.040).
对于OPN 1083 G/A变体,没有观察到任何显著的等位基因关联.

结论:

OPN 707 T/C 变种是欧洲和阿拉伯人口中SLE易感性的潜在遗传标志物.
在亚洲和阿拉伯人口中,OPN 9250 T/C 变种与 SLE 风险有关.
此外,OPN 1239 C/A 变种也显示出与SLE易感性的联系.

关键词:

骨质疏松素是一种骨质疏松素.一个小小的东西.这是一个元分析.变种变种变种变种变种

更多相关视频

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes

Published on: January 27, 2023

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

相关概念视频

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...